Skip to content

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05438940
Acronym
STRONG-GEC
Enrollment
23
Registered
2022-06-30
Start date
2022-07-15
Completion date
2025-06-12
Last updated
2026-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GastroEsophageal Cancer

Keywords

Nutrition Support

Brief summary

The purpose of the study is to assess the feasibility and patient satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides nutrition support for participants living with gastroesophageal cancer who are receiving chemotherapy and radiation treatment

Interventions

Participants will log food intake while sharing their data with a dietician in real time for 12 weeks

BEHAVIORALNutrition Counseling

Participants will receive individually tailored, bi-weekly nutrition counseling from a dietician via telehealth

BEHAVIORALSurvey

Participants will take a survey at baseline and weeks 4,8,12 \& 16. (FACT-G) Questionnaire includes questions about participant's physical, social, emotional and functional well being over the past 7 days. This questionnaire uses a 5 point Likert-type scale, 0=not at all, 4=very much. A higher total score indicates better quality of life.

Sponsors

H. Lee Moffitt Cancer Center and Research Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥18 years old * Locally advanced or metastatic GEC diagnosis * Planned to initiate chemoradiation and/or radiation therapy with a plan to have surgery or a plan to have definitive treatment at Moffitt. * Able to speak and read English * Able to provide informed consent

Exclusion criteria

* Documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., psychosis, active substance abuse) * Undergoing concurrent treatment for a secondary primary cancer * Use of feeding tubes before enrollment (The last exclusion criterion was included because investigators do not anticipate these participants would benefit from a dietary monitoring intervention)

Design outcomes

Primary

MeasureTime frameDescription
Recruitment Rate - Feasibility12 MonthsThe study will be deemed feasible if ≥ 50% of eligible participants are enrolled
Retention Rate - Feasibility12 MonthsThe study will be deemed feasible if ≥ 70% of participants enrolled at baseline will be retained at 8 weeks
Data Collection - Feasibility12 MonthsThe study will be deemed feasible if ≥ 60% of participants submit 3/4 study assessments
Participant Satisfaction - Acceptability12 MonthsThe study will be deemed acceptable if ≥ 70% of participants rate the overall intervention as satisfactory using a validated 4-item scale (score range 0-20).
Participant Rating on Ease of Use the Mobile Application - Usability12 MonthsThe study will be deemed usable if ≥ 60% of participants rate the mobile application as easy-to-use for logging dietary intake using a validated 10-item scale (score range from 0-100).

Secondary

MeasureTime frameDescription
Participant Compliance with Dietician Visit - Intervention adherence12 MonthsIntervention adherence will be deemed successful if ≥ 60% of participants meet with a dietician for 4/6 visits
Participant Compliance with Dietary Log - Intervention adherence12 MonthsIntervention adherence will be deemed successful if ≥ 60% of participants track food intake for 8/12 weeks

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKea Turner, PhD

Moffitt Cancer Center

PRINCIPAL_INVESTIGATORJose M Pimiento, MD

Moffitt Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 31, 2026